We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Next-Gen Automated ELISA System Elevates Laboratory Performance

By LabMedica International staff writers
Posted on 09 Jan 2026

A next-generation automated ELISA system is designed to elevate laboratory performance through advanced workflow automation, enhanced connectivity, and a modernized user experience. More...

DYNEX Technologies (Chantilly, VA, USA) has announced the commercial launch of the DS2 Elite automated ELISA system, which builds on the proven legacy of the DS2 system. The DS2 Elite supports laboratories as they move toward integrated operations and broader automation strategies. As laboratories seek to standardize processes, reduce manual touchpoints, and improve consistency, the DS2 Elite serves as a critical automation component – its compact footprint, flexible assay configuration, and automated sample processing allow users to integrate high-quality ELISA automation without sacrificing space or scalability.

Assay timing optimization, automated pre-wash steps, and improved dilution and mixing capabilities help ensure peak performance while minimizing hands-on time. The DS2 Elite introduces a comprehensive set of software and workflow enhancements that improve productivity, data integrity, and operational confidence for both new users and existing DYNEX customers. With Microsoft Windows 11 compatibility, stand-alone Co-Connect LIS interface software, and advanced security features, the system is engineered to meet the evolving demands of regulated clinical, reference, research, and biopharma laboratories.

Additionally, the platform includes a refreshed DYNEX-branded user interface and enhanced reporting tools that simplify daily operation and training. New user profiles and audit trail capabilities strengthen traceability and support regulatory compliance. Improved plate results reporting, increased photometric range, and Levey-Jennings quality control improvements provide greater confidence in data review and decision-making.

For existing DS2 customers, the DS2 Elite offers a seamless upgrade path with familiar workflows, expanded functionality, and reduced labor through automation improvements. For laboratories new to DYNEX, the system delivers an accessible entry point into automated ELISA testing with enterprise-level features typically reserved for higher-volume platforms.

"The launch of the DS2 Elite represents a meaningful step forward in how laboratories approach ELISA automation,” said Warren Robinson, Vice President of Global Commercial Business at DYNEX Technologies. "You are under increasing pressure to do more with less while maintaining accuracy, security and compliance. The DS2 Elite was designed to help you streamline workflows, protect data integrity, and confidently integrate ELISA automation."

Related Links:
DYNEX Technologies


Gold Member
Ketosis and DKA Test
D-3-Hydroxybutyrate (Ranbut) Assay
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Homocysteine Quality Control
Liquichek Homocysteine Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.